Newsletter - 0518-01
If you are having trouble viewing this e-mail, please click here.
 
 
 
 
#0518
 
 
Top Articles
 
 
I’m a (Biosimilars) Believer!
 
It’s been a long winding journey, but biosimilars are finally starting to shake up the biopharma market. Their true potential remains untapped, however – hindered by market access and myths around safety.
 
 
 
 
It Doesn’t Have To End In Tears
 
Rare diseases aren’t the only field that can benefit from repurposing – companies should also consider repurposing drugs for a much overlooked organ: the eye, says Jeremy Drummond from MedPharm.
 
 
 
 
Go Forth and Find a Flu Vaccine!
 
The Bill and Melinda Gates Foundation has issued a challenge and a huge amount of funding – up to $10 million upon proof of concept – to help researchers find a universal flu vaccine. The aim is to be ready for clinical trials by 2021.
 
 
 
 
 
 
 
Webinar
 
 
Cell Therapy Facilities – Designing for Flexibility, Scalability, and Cost Effectiveness
 
Looking to find out more about designing cell therapy facilities? In this webinar, experts give an introduction to the topic, discussing what operational, technical and support spaces are required, and how GMP and biocontainment requirements impact design. Mechanical and electrical needs – and how to address them – will also be considered.
 
 
 
 
Trials of a Medicine Maker
 
 
Asking the Right Questions
 
Eva likes to ensure her new suppliers are all on the ball (rather than relying on a dubious crystal ball)
 
 
 
 
Product Profile
 
 
Extended Capacity and Capabilities for Clinical Supply
 
Catalent has clinical supply sites in the US, UK, Germany and Asia, and an extended network of over 50 depots, to expedite clinical trials and ensure customers are reliably supplied around the globe.
 
 
 
 
Special Promotions
 
 
The Continuous Way
 
Why adopt continuous bioprocessing? Because it can lead to faster and more cost-effective biopharma manufacturing. In this supplement, Pall and their collaborators discuss the benefits of continuous bioprocessing and how Pall is innovating in this area.
 
 
 
Mastering mAb Manufacture
 
Experts share their tips and tricks for enhancing the production of monoclonal antiboides - Free eBook
 
 
 
Continuous Downstream Processing training programme
 
The BioFactory Competence Center (BCC) and Pall Biotech will offer a continuous downstream processing training course from 3rd - 5th July 2018, in Fribourg, Switzerland. Learn about the different technologies available for continuous processing steps including cell separation, filtration and chromatography in a hands-on laboratory with small scale sizes.
 
 
 
 
Exhibitor Highlight
 
 
Join SCIEX European Seminar Series Biologics Characterization Made Easy
 
SCIEX invites you to learn about the developments in analytical technologies for biopharmaceutical characterization using Mass Spectrometry and Capillary Electrophoresis. Register now for our seminars across Europe to hear about the latest innovations in routine and advanced workflows, Host Cell Protein clearance and N-Glycosylation analysis of antibody therapeutics.
 
 
 
 
Events
 
 
Upcoming Events
 
Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the industry – so why not take a look at our list of upcoming events?